Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Person-centred eHealth for Treatment and Rehabilitation of Severe Stress and Burnout Syndrome (PROMISE)

26 août 2020 mis à jour par: Göteborg University

Person-centred eHealth for Treatment and Rehabilitation of Severe Stress and Burnout Syndrome - a Randomized Controlled Trial in Primary Health Care

The goal of the research project PROMISE is to translate the person-centred care (PCC) principles into an eHealth (the use of information and communication technologies for health) context. A developed PCC eHealth platform will be used as a tool to identify patients´ resources to enhance coping and living with their illness by means of a dialog and partnership with staff and relatives. The PCC eHealth platform will not replace, but instead be used as add on treatment to usual care (guideline directed care).

Aperçu de l'étude

Description détaillée

A pilot study and collaboration between patients, relatives and professionals in the research program has clarified the need to develop a PCC eHealth platform. Previous research has shown that eHealth support, where the users are not involved in the process, has a low impact and has highlighted several limitations with respect to: patients' participation in the design process; its anchorage in the home and local environment and opportunities for communication rather than information. Therefore this study has a participatory design which assumes that all users (patients, relatives and health care professionals) are involved in the study design which facilitates implementation. An end-user perspective as a starting point increases the chances that users adapt a positive attitude towards the new system. Person-centred care combined with an eHealth support along the chain of health care showed a 4-fold chance of improved self-efficacy in combination with return to work or prior activity level after an event of acute coronary syndrome.

The aim of this project is that PCC can be delivered at distance and make health care more effective above and beyond usual care. Inclusion of the principles of PCC in an eHealth support for patients with stress, depression or anxiety will improve return to work rates, reduced relapse, reduce costs and improved self-efficacy.

In the PCC approach, the aims, capabilities and needs of each patient, will be the starting point. Self-care strategies will be reinforced and empowered.

This study is a randomized, open, parallel group intervention study where patients are eligible when they start their sick leave period due to stress, depression or anxiety. They will be asked about participation after being diagnosed and their sick leave has been approved.

Patients will be randomized into either the control or the intervention arm 1:1. The control group will receive usual care. The intervention group will receive usual care plus a PCC intervention through an eHealth platform. Randomization will be done through computer generated lists and stored in sealed envelopes.

Patients listed in primary care with a confirmed diagnosis of stress, depression or anxiety will be screened and sent an informing letter about the study from the chief at each centre. Specially trained registered nurses (RNs) will then screen patients against study inclusion and exclusion criteria and by phone contact eligible patients and inform the patient about the aims of the study and ask if they are interested to participate. If the patient wants to participate a consent form is sent to the patient and then returned to the RN. Written informed consent will then be obtained. Then the randomization procedure is performed which is stratified for age (≥ 50y) and diagnosis (stress, depression and anxiety) and the patient will be informed about the outcome by phone. Patients randomized to the intervention group will need a computer, smart phone or iPad to participate in the study.

Two dedicated full-time RNs follow the procedures closely. A monitor controls the protocol adherence. All case record forms, questionnaires and referrals will be constructed (for intervention and usual care groups).

Follow-up questionnaires on general self-efficacy, self-efficacy (self-care) quality of life, anxiety and depression, symptom burden and daily functional level will be sent out to all patients in both groups after 3,6,12,18 and 24 months after randomization.

Patients randomized to usual care will be managed by regular evidence-based treatment and care as outlined in treatment guidelines and followed as usual at their local primary care centre.

Patients will be contacted by a RN who has received special training in PCC communication at distance through the eHealth platform, for an initial person-centred dialogue by phone. Based on the patient narrative patient´s goals, resources and needs are identified. The patient (sometimes maybe together with relatives) and the RN formulate a person-centred health plan. This plan is part of and will be up-loaded to the eHealth platform which also contains individual notes and information about stress, depression and anxiety. The plan will be the point of departure for the forthcoming dialogue at distance via the eHealth platform that the patient and the RN will have during the study period (6 months).

The eHealth support contains headings that may inspire the patient to make notes on "a good day" respectively "a bad day" and register daily health related status. The health plan contain three parts; 1. "My goal is to feel or be able to do". 2. "To be able to reach my goal I will." 3."Support I need to reach my goal". In the communication during the study period between the RN and patient, the personal health plan is discussed and any needs of reformulating the goals may be discussed. The overall goal is to help the patient to identify their own capabilities/resources such as a strong will, social relations etc. and formulate goals that help them increase their self-efficacy and to cope with their condition in daily life.

The RN presents the eHealth support for communication (computer, iPad, smart phone) and they agree on how they will be in contact thereafter. The RN invites the patient and activates their account where he/she can login via an individual user name and formulate, comment, evaluate or develop the health plan. Access to the diary will be password protected. The RN can see the patient´s account and make comments. The patient can add or delete staff or private persons that have access to the account, and the patient can also limit the access for each user invited.

Type d'étude

Interventionnel

Inscription (Anticipé)

220

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Gothenburg, Suède
        • Primary Health Care

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 65 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

• Men and women fulfilling criteria for any of the following diagnoses: stress, depression or anxiety and on sick leave since ≤30 days

• Paid professional work, at least part time, during the last 9 months and willing to participate

Exclusion Criteria:

  • Sick leave >14 days for any of the above mentioned diagnoses during the last 3 months.
  • Severe impairment that prevents patient from using the eHealth support
  • No registered address
  • Not willing to participate
  • Any severe disease with an expected survival <12 months
  • Cognitive impairment
  • Ongoing documented diagnosis of alcohol or drug abuse
  • Other severe disease that can interfere with follow-up or if the intervention is assessed as a burden
  • Patient participating in another conflicting randomized study

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Soins de soutien
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Aucune intervention: Soins habituels
Soins fondés sur des données probantes
Expérimental: Person-centred care at distance
Person-centred care at distance through an eHealth platform
Soins centrés sur la personne à distance via une plateforme eHealth, utilisée par les professionnels, les patients et les proches

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Composite score of changes
Délai: baseline, 3, 6, 12, 18, 24 months

A patient is classified as improved, deteriorated or unchanged:

A patient is classified as improved if:

at 6 months reduced sick leave and increased general self-efficacy by ≥ 5 units

A patient is classified as deteriorated if:

at 6 months increased sick leave or (if on full-time sick leave at inclusion reduced general self-efficacy by ≥ 5 units)

Those who have neither deteriorated nor improved are considered unchanged

baseline, 3, 6, 12, 18, 24 months

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Sick leave
Délai: baseline, 3, 6, 12, 18, 24 months
Grade of sick leave
baseline, 3, 6, 12, 18, 24 months
General self-efficacy scale
Délai: baseline, 3, 6, 12, 18, 24 months
Questionnaire
baseline, 3, 6, 12, 18, 24 months
Health-related quality of Life (EQ-5D)
Délai: baseline, 3, 6, 12, 18, 24 months
Questionnaire
baseline, 3, 6, 12, 18, 24 months
Hospital anxiety and depression scale (HADS)
Délai: baseline, 3, 6, 12, 18, 24 months
Questionnaire
baseline, 3, 6, 12, 18, 24 months
Symptom burden (Shirom-Melamed Burnout Measure)
Délai: baseline, 3, 6, 12, 18, 24 months
Questionnaire
baseline, 3, 6, 12, 18, 24 months
Perceived stress scale (PSS)
Délai: baseline, 3, 6, 12, 18, 24 months
Questionnaire
baseline, 3, 6, 12, 18, 24 months
Self-rated burnout syndrome (s-UMS)
Délai: baseline, 3, 6, 12, 18, 24 months
Questionnaire
baseline, 3, 6, 12, 18, 24 months
Health care utilization
Délai: 3, 6, 12, 18, 24 months
Health care utilization
3, 6, 12, 18, 24 months
Incremental cost-utility ratios
Délai: 3, 6, 12, 18, 24 months
Incremental cost-utility ratios
3, 6, 12, 18, 24 months
Multidimensional fatigue symptom inventory (MFI-20)
Délai: 3, 6, 12, 18, 24 months
Questionnaire
3, 6, 12, 18, 24 months
Sheehan disability scale (SDS)
Délai: 3, 6, 12, 18, 24 months
Questionnaire
3, 6, 12, 18, 24 months
Self-efficacy (self-care)
Délai: 3, 6, 12, 18, 24 months
Questionnaire
3, 6, 12, 18, 24 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: Andreas Fors, PhD, Institute of health and care sciences, Centre for person-centred care (GPCC)

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

14 février 2018

Achèvement primaire (Anticipé)

31 janvier 2021

Achèvement de l'étude (Anticipé)

30 juin 2022

Dates d'inscription aux études

Première soumission

12 janvier 2018

Première soumission répondant aux critères de contrôle qualité

12 janvier 2018

Première publication (Réel)

19 janvier 2018

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

27 août 2020

Dernière mise à jour soumise répondant aux critères de contrôle qualité

26 août 2020

Dernière vérification

1 août 2020

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • PROMISE

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

Essais cliniques sur Santé mentale

S'abonner